| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 2 | |
| #2 | Canada | 2 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Mexico | 2 | |
| #5 | New Zealand | 2 | |
| #6 | WIPO (World Intellectual Property Organization) | 2 | |
| #7 | United Kingdom | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Agriculture | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Animal care | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms | |
| #5 | Analysing materials | |
| #6 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Villeneuve Anne | 6 |
| #2 | Gagne Marc | 6 |
| Publication | Filing date | Title |
|---|---|---|
| AU6653096A | Hybrid protein comprising t-helper cell stimulating epitopes and b-cell epitopes from the major outer membrane protein of chlamydia trachomatis and its use as a vaccine | |
| GB9509461D0 | DNA molecules and constructs and their use in the treatment of mastitis |